» Articles » PMID: 8184038

Nonpalpable Breast Tumors: Diagnosis with Contrast-enhanced Subtraction Dynamic MR Imaging

Overview
Journal Radiology
Specialty Radiology
Date 1994 Jun 1
PMID 8184038
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the accuracy of contrast material-enhanced subtraction dynamic magnetic resonance (MR) imaging in the diagnosis of nonpalpable breast tumors.

Materials And Methods: One hundred forty-three patients underwent surgical biopsy of a nonpalpable breast lesion. Their mammograms showed microcalcifications (n = 80), opacity (n = 52), architectural distortion (n = 10), or asymmetric density (n = 1). All patients underwent a preoperative gadolinium tetraazacyclododecanetetraacetic acid-enhanced subtraction dynamic study. Any early contrast enhancement in the breast parenchyma was considered pathologic.

Results: At histologic analysis, 27 intraductal carcinomas, 37 invasive carcinomas, and 79 benign lesions were found. Dynamic MR studies showed early contrast enhancement in 61 of 64 breast cancers (sensitivity, 95%) and in 37 of 79 benign lesions (specificity, 53%). Two invasive lobular carcinomas and one tubular carcinoma showed no early contrast enhancement.

Conclusion: Subtraction dynamic MR imaging may be helpful to rule out malignancy in nonpalpable breast tumors.

Citing Articles

Enhanced Detection of Residual Breast Cancer Post-Excisional Biopsy: Comparative Analysis of Contrast-Enhanced MRI with and Without Diffusion-Weighted Imaging.

Mun H, Kang B, Kim S, Park G Tomography. 2025; 11(1.

PMID: 39852690 PMC: 11769435. DOI: 10.3390/tomography11010010.


Breast Cancer Surrogate Subtype Classification Using Pretreatment Multi-Phase Dynamic Contrast-Enhanced Magnetic Resonance Imaging Radiomics: A Retrospective Single-Center Study.

Kovacevic L, Stajduhar A, Stemberger K, Korsa L, Marusic Z, Prutki M J Pers Med. 2023; 13(7).

PMID: 37511763 PMC: 10381456. DOI: 10.3390/jpm13071150.


K Calculation Using Reference Method Corrected Native T for Breast Cancer Diagnosis.

Negi P, Mehta S, Jena A, Rana P J Med Phys. 2023; 48(1):19-25.

PMID: 37342602 PMC: 10277302. DOI: 10.4103/jmp.jmp_90_22.


Missed Breast Cancers on MRI in High-Risk Patients: A Retrospective Case-Control Study.

Bilocq-Lacoste J, Ferre R, Kuling G, Martel A, Tyrrell P, Li S Tomography. 2022; 8(1):329-340.

PMID: 35202192 PMC: 8879993. DOI: 10.3390/tomography8010027.


Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.

Negi P, Mehta S, Jena A J Med Phys. 2021; 46(1):41-46.

PMID: 34267488 PMC: 8240908. DOI: 10.4103/jmp.JMP_2_20.